WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2012> 23> 2

Volume: 23 Issue: 2

1. Thrombopoietin: a novel candidate tumor marker for the diagnosis of ovarian cancer. Page:86—90
2. Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer. Page:91—97
3. Cut-off value of D-dimer for prediction of deep venous thrombosis before treatment in ovarian cancer. Page:98—102
4. Changes in biologic markers of oxidative stress and plasma endotoxin levels in gynecologic cancer patients treated with pelvic radiotherapy: a pilot study. Page:103—109
5. Does ductal lavage assert its role as a noninvasive diagnostic modality to identify women at low risk of breast cancer development?. Page:110—114
6. Photodynamic therapy for breast cancer in a BALB/c mouse model. Page:115—119
7. Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls. Page:120—124
8. Early diagnosis of malignant-transformed ovarian mature cystic teratoma: fat-suppressed MRI findings. Page:125—128
9. Successful pregnancy following transfer of frozen-thawed embryos in a patient with pseudomyxoma peritonei who underwent peritonectomy and bilateral oophorectomy. Page:129—132
10. HE4, CA-125, and cystic ovarian mass. Page:133—133
11. Telesurgery is promising but still need proof through prospective comparative studies. Page:134—135
12. Indications for endoscopy according to the revised FIGO staging for cervical cancer after MRI and CT scanning. Page:80—85
13. How to make the best strategy to manage thromboembolism in ovarian cancer?. Page:78—79
14. Three ongoing intraperitoneal chemotherapy trials in ovarian cancer. Page:75—77

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.